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Supplementary Information
Expression and purification of recombinant proteins.
His (6) -tagged Erk2 wild type or point mutants (N236K, Y261N, S264P and D319N), p38α, Erk1 and human MEK1 were expressed in E.coli and purified by Ni-NTA affinity chromatography according to the manufacturers protocol. Activated human Erk2 (Proqinase, Freiburg), inactive JNK2α (Millipore) and the glutathione S-tranferase/Elk1 fusion protein (GST-Elk1 residues 307-428, Cell Signalling Technologies (Danvers, MA, USA)) were commercially available and obtained from the respective vendor. The glutathione Stransferase-Elk1 fusion protein (GST-Elk1 residues 307-428) was purchased from Cell Signalling Technologies (Danvers, MA, USA). The kinases or kinase domains from RSK4, PKBγ, GRK2, VRK1, CK, DRAK1, AAK, NEK1 and TOPK were kindly provided by
Stephan Knapp, University of Oxford, UK.
Oligonucleotides, library preparation and in vitro selection.
The nucleic acid library was purchased from Metabion (Martinsried, Germany) as single chained DNA and amplified using the primers 5'-P-2.45 (5'-AATTCTAATACGACTCACTATA GGG AGA GAG CGA GAG GTA ACT AA-3') and 3´-C-20 (5´-GT CCT GTG GCA TCC ACG AAA-3´). Specifically, this nucleic acid library was synthesized to contain the original nucleotide found in the RNA aptamer TRA with a probability of 85% and 5% likelihood to harbour each of the three other nucleotides as described previously(40). The resultant dsDNA was used as a template for in vitro transcription. Transcribed RNA was purified by polyacrylamide gel electrophoresis and used as starting library for a selection process targeting pp-ERk2 according to a previously described protocol (12). The enriched library was cloned and sequenced and monoclonal aptamers assayed by filter retention analysis. The reaction was allowed to proceed for 2 hours at 37°C. Afterwards, the RNA was precipitated and purified as described elsewhere (12).
RNA-protein interaction analysis.
Radioactively labelled RNA was obtained by in vitro transcription reactions in the presence of and 5µl were used as competitors of radioactively labelled C5. The amount of radioactively labelled C5 bound to proteins was quantified as described above.
Erk2 activity assays.
Erk2 activity assays were performed in reaction buffer (20 mM Hepes, pH 7.4, 10 mM MgCl 2, 100 µM ATP suppl. with 1 µCi γ-[ 32 P]-ATP). 60 nM active Erk2 was incubated with 1 µM GST-Elk-1 and the indicated concentrations of aptamer or control RNA. Reactions were started by the addition of active Erk2. After incubation at 30°C for 15 min, the reaction was filtered through a nitrocellulose membrane and washed 3 times with washing buffer (20 mM Hepes, pH 7.4, 10 mM MgCl 2 ). γ-[ 32 P]-incorporation into GST-Elk1 was monitored and quantified as described above.
Pull-down of endogenous Erk 1/2.
Approximately 6x10 6 H460 cells were washed three times with ice-cold 1x PBS. Cells were collected with a cell scraper and collected by centrifugation (1000 g, 5 min, 4°C). The cell pellet was suspended in 1 ml 1x PBS (supplemented with 1% proteinase inhibitor mix, Serva, Heidelberg, Germany) and homogenized (Polytron, Kinematica, Luzern, Switzerland) at 4°C.
Afterwards, the cell suspension was centrifuged at 20.000 g for 60 minutes. The supernatant was then supplemented wit MgCl 2 and Heparin to final concentrations of 3 mM and 0.8 µg/µl, respectively. For pull-down experiments, a scrambled sequence of C5 ("C5sc" 5´-GACCGAGGACGGATCGCAGATGTCCGAGCTACACCATACACAGGCGAAGGAGTG ATTAATAGGTCTTGC-3´) was used as negative control. C5 and C5sc were biotinylated and coupled to magnetic beads as described previously (12). 200 pmol biotinylated RNA were incubated wit 0.5 mg streptavidin magnetic beads (Life Technologies, Carlsbad, CA, USA)
for 30 min at 22°C. After incubation, the cell lysate was added to the beads and incubated for 30 min at 37°C. Subsequently, the lysate was removed and the beads were washed 4x with 200 µl PBS supplemented with 3 mM MgCl 2 . Finally, the beads were suspended in 10 µl
MilliQ water and 4x Lämmli buffer, boiled for 5 min at 95°C and subjected to SDS-Page gel analysis. After Western blotting, the corresponding bands were detected with antibodies 4 specific to Erk1/2 (G12, Santa Cruz Biotechnology, Dallas, TX, USA) and DyLight-800 conjugated secondary antibodies (Thermo Scientific, Ulm, Germany). The corresponding bands were visualized with an Odyssey Imaging System (LiCor Biosciences, Lincoln, NE, USA).
Electrophysiology.
Male wtC57BL6 mice (aged 3-6 weeks) were anaesthetized with isoflurane and quickly decapitated. The brain was removed and transferred to ice-cold solution containing 60 mM NaCl, 100 sucrose, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 1 mM CaCl 2 , 5 mM MgCl 2 , and 20 mM glucose (pH 7.3). 350µm hippocampal slices were prepared with a vibratome (HM 650V, MICROM, Walldorf, Germany) and gradually warmed to 37°C. Slices were then transferred into aCSF containing 125 mM NaCl, 3.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 2 mM CaCl 2 , 2 mM MgCl 2 , and 15 mM glucose (pH 7.3) and allowed to equilibrate for at least 20 minutes at room temperature. All solutions were equilibrated with 95% O 2 /5% CO 2 . A cut was performed at the CA1/CA3 border to reduce afferent activity from the CA3 region.
Brain slices were subsequently transferred to a recording chamber perfused with aCSF additionally containing 10 µM GABAzine (SR-95531) to block g-aminobutyric acid (GABA) type A (GABA A ) receptors, Perfusion was adjusted to 2.5ml/min. CA1 pyramidal neurons were visually identified using infrared differential interference contrast microscopy. Patch pipettes were pulled from borosilicate glass (typically 3-5 MΩ) using a micro-pipette puller Temperature in the recording chamber was adjusted to 34°C. Current-clamp recordings were performed with a DaganIX-2-700 amplifier (Dagan Instruments, Minneapolis, USA) in "bridge" mode. A liquid junction potential between the intra-and extracellular solution was calculated as -14.9 mV and compensated. Series resistance was monitored and compensated regularly (every 2 minutes) throughout the experiment using the bridge circuitry. Experiments with series resistances > 30MΩ or a change > 20% during the recording were excluded.
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Synaptic EPSPs were evoked by electrical stimulation with a glass pipette filled with aCSF (tip diameter ≈ 4µM, duration of stimulation 50µs) with a stimulus isolator (AM-Systems, Model 2100, Sequim, WA, USA). The stimulation pipette was placed in the stratum radiatum 220-320µM from the CA1 pyramidal soma. Stimulus intensities were adjusted to produce EPSP amplitudes of ~2 mV. After establishing whole-cell recordings, at least 5 minutes were allowed to elapse for stabilization. EPSPs were then recorded every 2 minutes (10 sweeps, 0.2 Hz). In all cells, at least 10 minutes of stable baseline recording was achieved. Following tetanisation, EPSPs were monitored for at least 30 minutes. The membrane potential was adjusted to -75 mV using DC current injection.
For LTP induction, Schaffer collaterals were stimulated with bursts of five stimulations at 100
Hz, repeated in 10 trains of 5Hz. Action potentials were induced by current injection (5ms) during the last two of the 5 100 Hz stimulations ( Voltage signals were sampled at 50 kHz, filtered at 5 kHz and digitized (Digidata 1322A, Molecular Devices, CA, USA). They were saved on the computer hard disk for later analysis.
Data were analysed using Igor Pro software (WaveMetrics Inc., Lake Oswego, OR, USA). All comparisons were made using Wilcoxon rank tests with a-level of 0.05 considered significant.
All drugs were from Sigma, St Louis, MO, USA unless otherwise specified.
Two-photon fluorescence imaging
To establish the presence of C5 aptamer in the distal dendrites, cells were filled with C5 conjugated to Fluorescein (10 µM) and Alexa594 (100 µM) to visualize neuron morphology.
Cells were imaged using a Ti:Sapphire ultrafast-pulsed laser (Chameleon Ultra II, Coherent, Santa Clara, USA) and a galvanometer-based scanning system (Prairie Technologies, Erk2 is reduced in PBS buffer with 3 mM MgCl 2 . This loss of interaction is not attributed to the lower MgCl 2 concentration (3 mM) used in PBS buffer compared to the Hepes buffer, c) Binding of TRA to Erk2 in a buffer containing 10 mM Hepes, pH 7,4, 10 mM MgCl 2 (10 mM MgCl2) and 2.7 mM KCl (10 mM MgCl2 + KCl) or 130 mM NaCl (10 mM MgCl2 + NaCl). The addition of KCl induces a strong reduction of affinity of TRA to Erk2. All experiments were performed at least twice (mean ± SEM). 
